Posted May. 15, 2012 at 6:59 a.m.

Premium Lock Cary-based Cornerstone buys drug firm in $150M deal

Published: 2012-05-15 06:59:10
Updated: 2012-05-15 06:59:10

Print this blog post
Drug deal Drug deal Image 1 of 2 · Next Image…

Cornerstone Therapeutics has reached a preliminary agreement to acquire acute-care hospital products company EKR Therapeutics and the rights to two of its drugs in a deal valued at up to $150 million....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Scroll